Roche - Bristol Myers Partnership Will Leverage PathAI's Platform

Today Roche announced a new collaboration with Bristol Myers Squibb that will use cutting edge digital methods to improve standardization and interpretation of tissue-based assays and will leverage Roche's established partnership with PathAI. Roche plans to integrate a novel PathAI-developed algorithm for biomarker analysis into their digital pathology workflow software. The AI-powered algorithm will be used to analyze clinical trial samples and generate biomarker data. These imaging tools will enable very precise diagnoses that will lead to personalized treatment options for patients with solid tumors. In October 2021, Roche announced a strategic partnership with PathAI.